Slate Auto's $650M Series C Tops Weekly U.S. Venture Deals; Biotech, Autonomous Transit Also Score Big

Electric vehicle manufacturer Slate Auto secured $650 million in Series C funding, topping a week of substantial U.S. venture capital deals. Investments totaling hundreds of millions also flowed into biotech and autonomous transportation sectors.

U.S. startups attracted significant capital this week, with multiple companies announcing funding rounds exceeding $100 million. The largest investments concentrated in electric vehicles, advanced biotechnology, and autonomous transit solutions. This reflects sustained investor interest in innovation across critical infrastructure and healthcare domains.

Troy, Michigan-based Slate Auto, a developer of customizable electric pickup trucks, raised $650 million in Series C funding. TWG Global led this round for the company, which plans its first vehicle deliveries this year. This financing represents the highest single U.S. venture deal of the past week.

Biotech company Beeline Medicines emerged from stealth with $300 million in Series A funding. Bain Capital led the investment into the Boston-based firm, which focuses on precision therapies for autoimmune and inflammatory diseases. The company’s initial portfolio includes five programs licensed from Bristol Myers Squibb.

San Francisco-based Glydways secured $170 million in Series C funding for its personal autonomous pods, which operate on dedicated lanes. Suzuki Motor, ACS Group, and Khosla Ventures led this round as Glydways prepares to launch operational pilots in three cities this year. Another major investment went to Factory, an AI (artificial intelligence) software engineering startup, which closed a $150 million Series C round led by Khosla Ventures.

Further biotech funding included Terremoto Biosciences, which secured $108 million in Series C for small molecule medicines. Additionally, Neomorph raised $100 million in Series B funding for cancer therapeutics. Financial technology also drew capital, with Slash, a business banking platform, picking up $100 million in a Series C round. Slash reported surpassing $250 million in annualized revenue in 2025.

This week’s venture activity underscores strong investor confidence in sectors poised for significant disruption and growth. Electric vehicles, advanced drug development, and autonomous systems continue to attract substantial capital. These investments aim to fuel product development and market expansion across diverse high-tech industries.

Observers will track how these capital infusions accelerate innovation and bring new products and services to market in the coming months.